All monologues are property and copyright of their owners. Monologues are presented on MightyActor for educational purposes only .
A monologue from the play by Kate Fodor
ALLISON (thirties-forties)
Allison is the Marketing Director for a large pharmaceuticals company.
At a shareholders’ meeting, she reveals that the company has a new drug in development which will alleviate workplace depression.
wow, great presentation. Thanks, Carl. It’s always good to hear about what’s going on in the cardiology business unit.
They’ve got a lot of heart over there. For those of you who haven’t heard me speak at a shareholder’s meeting before,
I’m Allison Hardy, MBA, team leader of the Neurology Business Unit here at Schmidt Pharma.
One of the things we are especially excited to share with you this year is a development-stage drug we’ve code-named SP-925,
which targets workplace depression, a newly identified—and we believe eminently treatable—disease caused by a startling drop in norepinephrine levels during the working day.
Plummeting norepinephrine levels leave some sufferers listless and unproductive, while others become agitated and difficult to work with.
Anyone have a colleague they’d like to volunteer for our clinical trial? Put your hands down, I’m kidding!
we’re in the process of pre-screening subjects for the first major efficacy trial of SP-925,
and we’ll have that data to present to you at the next annual Schmidt Pharma shareholders meeting, assuming all goes well.
And while I am required by the SEC to caution you that my presentation today has contained forward-looking statements
that are not guarantees of future performance and involve a number of risks and uncertainties, I assure you that I intend to personally see to it that all goes well.
Now ask me some questions so I can stay up here a little longer. I love it up here.
Check out our monologue archive below for more monologues.